Two firms had entered into a licensing agreement for investigational drug tildrakizumab in July 2016
Trastuzumab (Herceptin) is one of the 6 biologic products co-developed by Mylan & Biocon
Move clears the way for supply of products from Mohali facility to the US market
US FDA had conducted an inspection at Alkem's Baddi facility from March 2-10, 2017
Merck has a strategic alliance with India's Dr Reddy's Labs to co-develop multiple cancer drugs
It will sell this business to Ascendis Health for Rand 375 million (about Rs 192 crores)
They have signed pact for a generic version of Merck & Co's NuvaRing, a contraceptive vaginal ring
The company has also received US drug regulator's nod for generic Percocet tablet, a pain killer
It has also received approval for clobetasol propionate spray, used for skin treatment
It will enhance Allergan's medical aesthetics portfolio with addition of CoolSculpting system
The move is aimed at reducing the manufacturing cost of drugs and medical devices
UK scientists found that E.coli bacteria increased antibiotic resistance with each treatment
The unit mainly conducted drug discovery research targeting infectious diseases & inflammation
Acquisition significantly enhances Takeda's global oncology portfolio
Tablet is a generic version of MS Contin ER, which had annual US sales of $ 282.9 mn
Immatics to receive $ 30 mn upfront & potentially over $ 1 bn in milestone payments & royalties
The approved product is a generic version of Eli Lilly & Co's Cymbalta capsule
Infarmed, Portugal, issued these observations for Granules India's Gagillapur facility
The deal will help Aurobindo to establish itself as one of the leading generics players in Europe
The court has prohibited Sanofi & Regeneron from infringing two patents that Amgen holds for Repatha